SELLAS Life Sciences Group, Inc. Basic Shares Outstanding (Weighted Average)
SELLAS Life Sciences Group, Inc. (SLS) reported Basic Shares Outstanding (Weighted Average) of 189.18 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-11
- SELLAS Life Sciences Group, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 189.18M shares, a 91.95% increase year-over-year.
- SELLAS Life Sciences Group, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 172.48M shares, a 96.54% increase year-over-year.
- SELLAS Life Sciences Group, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 141.26M shares, a 90.93% increase year-over-year.
- SELLAS Life Sciences Group, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 108.40M shares, a 58.81% increase year-over-year.
- SELLAS Life Sciences Group, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 109.05M shares, a 78.18% increase from fiscal 2024.
- SELLAS Life Sciences Group, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 61.20M shares, a 120.33% increase from fiscal 2023.
- SELLAS Life Sciences Group, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 27.78M shares, a 43.21% increase from fiscal 2022.
- SELLAS Life Sciences Group, Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 19.40M shares, a 25.29% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | 189.18M shares 10-Q · filed 2026-08-11 | 180.88M shares 10-Q · filed 2026-08-11 | 167.64M shares derived: average of 3 quarters · filed 2026-08-11 | 152.83M shares derived: average of 4 quarters · filed 2026-08-11 | |||
| 2026-03-31 | 172.48M shares 10-Q · filed 2026-05-12 | 156.87M shares derived: average of 2 quarters · filed 2026-05-12 | 140.71M shares derived: average of 3 quarters · filed 2026-05-12 | 130.17M shares derived: average of 4 quarters · filed 2026-08-11 | |||
| 2025-12-31 | 141.26M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | 124.83M shares derived: average of 2 quarters · filed 2026-03-19 | 116.07M shares derived: average of 3 quarters · filed 2026-08-11 | 109.05M shares 10-K · filed 2026-03-19 | |||
| 2025-09-30 | 108.40M shares 10-Q · filed 2025-11-12 | 103.48M shares derived: average of 2 quarters · filed 2026-08-11 | 98.31M shares 10-Q · filed 2025-11-12 | 92.18M shares derived: average of 4 quarters · filed 2026-08-11 | |||
| 2025-06-30 | 98.56M shares 10-Q · filed 2026-08-11 | 93.19M shares 10-Q · filed 2026-08-11 | 86.77M shares derived: average of 3 quarters · filed 2026-08-11 | 82.14M shares derived: average of 4 quarters · filed 2026-08-11 | |||
| 2025-03-31 | 87.76M shares 10-Q · filed 2026-05-12 | 80.87M shares derived: average of 2 quarters · filed 2026-05-12 | 76.67M shares derived: average of 3 quarters · filed 2026-05-12 | 71.91M shares derived: average of 4 quarters · filed 2026-05-12 | |||
| 2024-12-31 | 73.99M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | 71.12M shares derived: average of 2 quarters · filed 2026-03-19 | 66.62M shares derived: average of 3 quarters · filed 2026-03-19 | 61.20M shares 10-K · filed 2026-03-19 | |||
| 2024-09-30 | 68.25M shares 10-Q · filed 2025-11-12 | 62.94M shares derived: average of 2 quarters · filed 2025-11-12 | 56.94M shares 10-Q · filed 2025-11-12 | 50.38M shares derived: average of 4 quarters · filed 2025-11-12 | |||
| 2024-06-30 | 57.63M shares 10-Q · filed 2025-08-12 | 51.22M shares 10-Q · filed 2025-08-12 | 44.42M shares derived: average of 3 quarters · filed 2025-08-12 | 40.40M shares derived: average of 4 quarters · filed 2025-08-12 | |||
| 2024-03-31 | 44.81M shares 10-Q · filed 2025-05-13 | 37.81M shares derived: average of 2 quarters · filed 2025-05-13 | 34.66M shares derived: average of 3 quarters · filed 2025-05-13 | 33.08M shares derived: average of 4 quarters · filed 2025-05-13 | |||
| 2023-12-31 | 30.80M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | 29.58M shares derived: average of 2 quarters · filed 2025-03-20 | 29.17M shares derived: average of 3 quarters · filed 2025-03-20 | 27.78M shares 10-K · filed 2025-03-20 | |||
| 2023-09-30 | 28.36M shares 10-Q · filed 2024-11-13 | 28.35M shares derived: average of 2 quarters · filed 2024-11-13 | 26.77M shares 10-Q · filed 2024-11-13 | 25.26M shares derived: average of 4 quarters · filed 2024-11-13 | |||
| 2023-06-30 | 28.35M shares 10-Q · filed 2024-08-13 | 25.96M shares 10-Q · filed 2024-08-13 | 24.23M shares derived: average of 3 quarters · filed 2024-08-13 | 23.31M shares derived: average of 4 quarters · filed 2024-08-13 | |||
| 2023-03-31 | 23.55M shares 10-Q · filed 2024-05-14 | 22.17M shares derived: average of 2 quarters · filed 2024-05-14 | 21.63M shares derived: average of 3 quarters · filed 2024-05-14 | 21.30M shares derived: average of 4 quarters · filed 2024-05-14 | |||
| 2022-12-31 | 20.79M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | 20.67M shares derived: average of 2 quarters · filed 2024-03-28 | 20.54M shares derived: average of 3 quarters · filed 2024-03-28 | 19.40M shares 10-K · filed 2024-03-28 | |||
| 2022-09-30 | 20.56M shares 10-Q · filed 2023-11-09 | 20.42M shares derived: average of 2 quarters · filed 2023-11-09 | 18.93M shares 10-Q · filed 2023-11-09 | 18.16M shares derived: average of 4 quarters · filed 2023-11-09 | |||
| 2022-06-30 | 20.29M shares 10-Q · filed 2023-08-10 | 18.10M shares 10-Q · filed 2023-08-10 | 17.36M shares derived: average of 3 quarters · filed 2023-08-10 | 16.99M shares derived: average of 4 quarters · filed 2023-08-10 | |||
| 2022-03-31 | 15.90M shares 10-Q · filed 2023-05-11 | 15.89M shares derived: average of 2 quarters · filed 2023-05-11 | 15.89M shares derived: average of 3 quarters · filed 2023-05-11 | 15.73M shares derived: average of 4 quarters · filed 2023-05-11 | |||
| 2021-12-31 | 15.89M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | 15.88M shares derived: average of 2 quarters · filed 2023-03-16 | 15.68M shares derived: average of 3 quarters · filed 2023-03-16 | 15.48M shares 10-K · filed 2023-03-16 | |||
| 2021-09-30 | 15.87M shares 10-Q · filed 2022-11-14 | 15.57M shares derived: average of 2 quarters · filed 2022-11-14 | 15.34M shares 10-Q · filed 2022-11-14 | 14.10M shares derived: average of 4 quarters · filed 2022-11-14 | |||
| 2021-06-30 | 15.27M shares 10-Q · filed 2022-08-11 | 15.07M shares 10-Q · filed 2022-08-11 | 13.51M shares derived: average of 3 quarters · filed 2022-08-11 | 12.24M shares derived: average of 4 quarters · filed 2022-08-11 | |||
| 2021-03-31 | 14.88M shares 10-Q · filed 2022-05-12 | 12.63M shares derived: average of 2 quarters · filed 2022-05-12 | 11.23M shares derived: average of 3 quarters · filed 2022-05-12 | 10.10M shares derived: average of 4 quarters · filed 2022-05-12 | |||
| 2020-12-31 | 10.38M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | 9.40M shares derived: average of 2 quarters · filed 2022-03-31 | 8.51M shares derived: average of 3 quarters · filed 2022-03-31 | 7.98M shares 10-K · filed 2022-03-31 | |||
| 2020-09-30 | 8.42M shares 10-Q · filed 2021-11-12 | 7.57M shares derived: average of 2 quarters · filed 2021-11-12 | 7.17M shares 10-Q · filed 2021-11-12 | ||||
| 2020-06-30 | 6.72M shares 10-Q · filed 2021-08-12 | 6.55M shares 10-Q · filed 2021-08-12 | |||||
| 2017-09-30 | 39.25M shares 10-Q · filed 2017-11-09 | 38.34M shares derived: average of 2 quarters · filed 2017-11-09 | 34.41M shares 10-Q · filed 2017-11-09 | ||||
| 2017-06-30 | 37.42M shares 10-Q · filed 2017-08-14 | 31.94M shares 10-Q · filed 2017-08-14 | |||||
| 2017-03-31 | 26.41M shares 10-Q · filed 2017-05-10 | ||||||
| 2016-09-30 | 10.47M shares 10-Q · filed 2017-11-09 | 209.30M shares 10-Q · filed 2016-11-09 | 9.78M shares derived: average of 2 quarters · filed 2017-11-09 | 9.52M shares 10-Q · filed 2017-11-09 | 190.31M shares 10-Q · filed 2016-11-09 | ||
| 2016-06-30 | 9.10M shares 10-Q · filed 2017-08-14 | 182.03M shares 10-Q · filed 2016-08-09 | 9.04M shares 10-Q · filed 2017-08-14 | 180.70M shares 10-Q · filed 2016-08-09 | |||
| 2016-03-31 | 8.97M shares 10-Q · filed 2017-05-10 | ||||||
| 2015-09-30 | 161.86M shares 10-Q · filed 2016-11-09 | 161.62M shares derived: average of 2 quarters · filed 2016-11-09 | 153.00M shares 10-Q · filed 2016-11-09 | ||||
| 2015-06-30 | 161.38M shares 10-Q · filed 2016-08-09 | 148.65M shares 10-Q · filed 2016-08-09 | |||||
| 2013-06-30 | 83.66M shares 10-Q · filed 2013-08-09 | 83.33M shares 10-Q · filed 2013-08-09 | |||||
| 2012-06-30 | 65.11M shares 10-Q · filed 2013-08-09 | 56.55M shares 10-Q · filed 2013-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |